Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 73Carcinoma, Renal Cell 36Urinary Bladder Neoplasms 25Carcinoma, Transitional Cell 14Neoplasm Metastasis 12Melanoma 12Ovarian Neoplasms 11Lung Neoplasms 11Colorectal Neoplasms 11Clear-cell metastatic renal cell carcinoma 10Carcinoma, Non-Small-Cell Lung 9Breast Neoplasms 9Wilms Tumor 8Ureteral Neoplasms 8Pancreatic Neoplasms 8Carcinoma, Hepatocellular 8Lymphoma, Non-Hodgkin 7Glioma 7Urethral Neoplasms 6Sarcoma 6Neuroblastoma 6Hepatoblastoma 6Uterine Cervical Neoplasms 5Rhabdoid Tumor 5Osteosarcoma 5Neuroectodermal Tumors, Primitive, Peripheral 5Medulloblastoma 5Histiocytosis, Langerhans-Cell 5Ependymoma 5Central Nervous System Neoplasms 5

Interventions

pembrolizumab 2enfortumab vedotin 2Nivolumab 2Gemcitabine 2Cisplatin 2sacituzumab govitecan 1relatlimab 1erdafitinib 1avelumab 1Vinblastine 1Specimen Handling 1Paclitaxel 1Methotrexate 1Magnetic Resonance Spectroscopy 1Immunoglobulin G 1Disulfides 1Cystoscopy 1Circulating Tumor DNA 1Cell-Free Nucleic Acids 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Muscle Invasive Bladder Urothelial Carcinoma × Specimen Handling × Genitourinary × Clear all
NCT05987241 2026-06-03

Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder, Kidney, Ureter, and Urethra for Urothelial Cancer Treatment, MODERN Study

National Cancer Institute (NCI)

Phase 2/3 Recruiting
992 enrolled
Genitourinary

Muscle Invasive Bladder Urothelial Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡